Prothrombin 20210A mutation: A mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study

Archives of Internal Medicine

Volumn 164, Issue 17, 2004, Pages 1932-1937

  Bank, Ivan ^a,d   Libourel, Eduard J ^b   Middeldorp, Saskia ^a   Van Pampus, Elisabeth C M ^c   Koopman, Maria M W ^a   Hamulyak, Karly ^c   Prim, Martin H ^c   Van Der Meer, Jan ^b   Büller, Harry R ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOTYPE; HEART INFARCTION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROTHROMBIN; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 4644268361     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.17.1932     Document Type: Article

References (37)

1. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703.
2. Arruda VR, Annichino-Bizzacchi JM, Goncalves MS, Costa FF. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost. 1997;78:1430-1433.
3. Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood. 1997;90:1747-1750.
4. Watzke HH, Schuttrumpf J, Graf S, Huber K, Panzer S. Increased prevalence of a polymorphism in the gene coding for human prothrombin in patients with coronary heart disease. Thromb Res. 1997;87:521-526.
5. Martinelli I, Taioli E, Bucciarelli P, Akhavan S, Mannucci PM. Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis. Arterioscler Thromb Vasc Biol. 1999;19:700-703 .
6. Franco RF, Trip MD, ten Gate H, et al. The 20210 G→A mutation in the 3′-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. Br J Haematol. 1999;104:50-54.
7. Eichinger S, Minar E, Hirschl M, et al. The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene. Thromb Haemost. 1999;81:14-17.
8. Larsson J, Hillarp A. The prothrombin gene G20210A mutation and the platelet glycoprotein Ilia polymorphism PI(A2) in patients with central retinal vein occlusion. Thromb Res. 1999;96:323-327.
9. De Stefano V, Martinelli I, Mannucci PM, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med. 1999;341:801-806.
10. Aznar J, Vaya A, Estelles A, et al. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Haematologica. 2000;85:1271-1276.
11. De Stefano V, Martinelli I, Mannucci PM, et al. The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation. Br J Haematol. 2001;113:630-635.
12. Kibbe MR, Cortese HA, McSherry F, et al. Can screening for genetic markers improve peripheral artery bypass patency? J Vasc Surg. 2002;36:1198-1206.
13. Vaya A, Mira Y, Mateo J, et al. Prothrombin G20210A mutation and oral contraceptives increase upper-extremity deep vein thrombotic risk. Thromb Haemost. 2003;89:452-457.
14. Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation. 1999;99:999-1004.
15. Russo C, Girelli D, Olivieri O, et al. G20210A prothrombin gene polymorphism and prothrombin activity in subjects with or without angiographically documented coronary artery disease. Circulation. 2001;103:2436-2440.
16. Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group. No evidence of association between prothrombic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation. 2003;107:1117-1128.
17. Boekholdt SM, Bijsterveld NR, Moons AM, Buller HR, Peters RG. Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation. 2001;104:3063-3068.
18. Arias F, Romero R, Joist H, Kraus FT. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern Fetal Med. 1998;7:277-286.
19. Grandone E, Margaglione M, Colaizzo D, et al. Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A(20210) mutations. Haematologica. 2002;87:177-181.
20. Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 1999;340:9-13.
21. Pihusch R, Buchholz T, Lohse P, et al. Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester. Am J Reprod Immunol. 2001;46:124-131.
22. Rey E, Kahn S, David M, Schrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet. 2003;361:901-908.
23. Stirrat GM. Recurrent miscarriage, I: definition and epidemiology. Lancet. 1990;336:673-675.
24. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142:159-167.
25. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988;158:892-898.
26. Lensen RM, Bertina RM, de Ronde H, Vandenbroucke JP, Rosendaal FR. Venous thrombotic risk in family members of unselected individuals with factor V Leiden. Thromb Haemost. 2000;83:817-821.
27. Martinelli I, de Stefano V, Taioli E, Paciaroni K, Rossi E, Mannucci PM. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Thromb Haemost. 2003;87:791-795.
28. McColl MD, Ellison J, Reid F, Tait RC, Walker ID, Greer IA. Prothrombin 20210 G→A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy. BJOG. 2000;107:565-569.
29. Middeldorp S, Henkens CM, Koopman MM, et al. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis. Ann Intern Med. 1998;128:15-20.
30. Simioni P, Sanson BJ, Prandoni P, et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost. 1999;81:198-202.
31. Longstreth WTJ, Rosendaal FR, Siscovick DS, et al. Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A). Stroke. 1998;29:577-580.
32. Ardissino D, Mannucci PM, Merlini PA, et al. Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood. 1999;94:46-51.
33. Bieber FR, Driscoll SG. Evaluation of early pregnancy loss. In: Reed GB, Claireaux AE, Cockburn F, eds. Diseases of the Fetus and Newborn. 2nd ed. London, England: Chapman & Hall; 1995:175-186.
34. Rosendaal FR, Heijboer H, Briet E, et al. Mortality in hereditary antithrombin-III deficiency-1830 to 1989. Lancet. 1991;337:260-262.
35. Thorn TJ, Epstein FH. Heart disease, cancer, and stroke mortality trends and their interrelations: an international perspective. Circulation. 1994;90:574-582.
36. Simioni P, Tormene D, Prandoni P, et al. Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study. Blood. 2002;99:1938-1942.
37. Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med. 1992;232:155-160.